Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...
Inhaled maintenance therapy is underused among hospitalized patients with COPD in China, even in those with frequent prior hospitalizations.
The European approval for GSK's depemokimab joins recently announced data on vaccine efficacy and progress on 4-month viral treatments.
The approval of Exdensur (depemokimab) for severe asthma and chronic rhinosinusitis with nasal polyps by the European ...
A Galveston woman says she is out more than 8,000 dollars after canceling a Princess cruise for her 89-year-old friend whose worsening cancer and COPD triggered a denied travel protection claim tied ...
Construction sites can be paused for one or two months or at least have strict dust and pollution control measures, suggested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results